Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy

Gastrin acts physiologically as a gut hormone to stimulate acid secretion after meal and as a cell-growth factor of oxyntic mucosa. Increase in serum gastrin level happens under various conditions including Zollinger-Ellison syndrome, antral G cell hyperplasia, autoimmune gastritis, atrophic gastritis, renal failure, vagotomy, Helicobacter pylori infection and acid suppressive therapy. As acid suppressive therapy causes hypergastrinemia, the association between acid suppressive therapy and gastric neuroendocrine cell tumor (NET) has been discussed during the past 30 years. In this review article, the definition of hypergastrinemia and the related disorders including acid suppressive therapy and gastric NET are discussed.

[1]  T. Eguchi,et al.  The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors , 2017, Digestion.

[2]  Y. Fujiwara,et al.  Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease , 2017, Digestion.

[3]  K. Iwakiri,et al.  Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis , 2017, Digestion.

[4]  O. Yokosuka,et al.  Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post‐endoscopic submucosal dissection: A propensity score‐matching analysis , 2017, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[5]  K. Haruma,et al.  Optimal acid suppressive treatment for adequate symptom relief and prevention of the complications of gastroesophageal reflux disease: differences in long-term clinical course and pathophysiology among disease subtypes , 2017, Esophagus.

[6]  T. Eguchi,et al.  A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori , 2016, Digestion.

[7]  T. Kagawa,et al.  Vonoprazan prevents bleeding from endoscopic submucosal dissection‐induced gastric ulcers , 2016, Alimentary pharmacology & therapeutics.

[8]  K. Murakami,et al.  Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study , 2016, Gut.

[9]  N. Hiramatsu,et al.  Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis , 2015, Alimentary pharmacology & therapeutics.

[10]  D. McCarthy,et al.  Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature , 2016, Digestive Diseases and Sciences.

[11]  Y. Sakurai,et al.  Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study , 2015, Alimentary pharmacology & therapeutics.

[12]  M. Vieth,et al.  Systematic review: the effects of long‐term proton pump inhibitor use on serum gastrin levels and gastric histology , 2015, Alimentary pharmacology & therapeutics.

[13]  B. Toh.  Diagnosis and classification of autoimmune gastritis. , 2014, Autoimmunity reviews.

[14]  R. Jensen,et al.  Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis , 2014, Journal of Gastroenterology.

[15]  R. Mårvik,et al.  Gastric carcinoids after long‐term use of a proton pump inhibitor , 2012, Alimentary pharmacology & therapeutics.

[16]  R. Jensen,et al.  Serum Gastrin in Zollinger-Ellison Syndrome: I. Prospective Study of Fasting Serum Gastrin in 309 Patients From the National Institutes of Health and Comparison With 2229 Cases From the Literature , 2006, Medicine.

[17]  G. Dockray,et al.  Gastrin: old hormone, new functions , 2004, Pflügers Archiv.

[18]  K. Haruma,et al.  Effect of age and Helicobacter pylori infection on gastric acid secretion , 2000, Journal of gastroenterology and hepatology.

[19]  G. Dockray.  Gastrin and gastric epithelial physiology , 1999 .

[20]  K. Haruma,et al.  The association between antral G and D cells and mucosal inflammation, atrophy, and Helicobacter pylori infection in subjects with normal mucosa, chronic gastritis, and duodenal ulcer , 1998, American Journal of Gastroenterology.

[21]  K. Haruma,et al.  Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. , 1995, The American journal of gastroenterology.

[22]  K. Haruma,et al.  Helicobacter pylori infection is associated with low antral somatostatin content in young adults. Implications for the pathogenesis of hypergastrinemia. , 1995, Scandinavian journal of gastroenterology.

[23]  K. Haruma,et al.  Helicobacter pylori infection, serum gastrin, and gastric acid secretion in teen-age subjects with duodenal ulcer, gastritis, or normal mucosa. , 1995, Scandinavian journal of gastroenterology.

[24]  W. Creutzfeldt,et al.  The consequences of hypergastrinemia. , 1994, The Yale journal of biology and medicine.

[25]  K. Haruma,et al.  Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. , 1993, Scandinavian journal of gastroenterology.

[26]  L. Ekman,et al.  Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. , 1990, Digestion.

[27]  J. Walsh.  Role of gastrin as a trophic hormone. , 1990, Digestion.

[28]  R. Playford,et al.  CAMPYLOBACTER PYLORI AND DUODENAL ULCERS: THE GASTRIN LINK , 1989, The Lancet.

[29]  R. Jensen,et al.  Zollinger-Ellison syndrome. Current concepts in diagnosis and management. , 1987, The New England journal of medicine.

[30]  F. Sundler,et al.  Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. , 1986, Gastroenterology.

[31]  M. Irie,et al.  [Radioimmunoassay of gastrin]. , 1971, Saishin igaku. Modern medicine.

[32]  S. Berson,et al.  Radioimmunoassay of gastrin. , 1970, Gastroenterology.

[33]  R. A. Gregory,et al.  The constitution and properties of two gastrins extracted from hog antral mucosa , 1964, Gut.